DBVT Q3 2018 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+57.8% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$51M-1709.4% margin

Net Income

-$51M-1709.4% margin

EPS (Diluted)

$-5.40

QoQ Revenue Growth

-12.5%

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$60M

Stock-Based Comp.

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+57.8%
Gross Profit	$3M	$2M	+57.8%
Operating Income	-$51M	-$44M	-16.9%
Net Income	-$51M	-$44M	-14.9%